FDA Greenlights Gene-Editing Technology for Breeding PRRS-Resistant Swine

May 17, 2025 - 13:00

In a significant advancement for the agricultural sector, the FDA has approved a groundbreaking gene-editing technology aimed at breeding swine resistant to Porcine Reproductive and Respiratory Syndrome (PRRS). This disease has long posed a severe threat to pig populations, leading to substantial economic losses for farmers and the industry as a whole.

The newly approved technology utilizes precise gene-editing techniques to enhance the immune response of pigs, making them less susceptible to PRRS. This development is expected to revolutionize swine production, allowing farmers to raise healthier animals while reducing the reliance on antibiotics and other treatments traditionally used to combat disease.

Experts in the field are optimistic about the potential impact of this technology on food security and animal welfare. By fostering a more resilient swine population, the industry can improve productivity and sustainability. As the implementation of this gene-editing technology begins, it signals a new era in livestock management and disease prevention strategies.